Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Outcome probabilities for the whole population

From: Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT

 

2 years

5 years

10 years

OS (95% CI)

66.8% (62.8 - 70.4)

53.3% (49 - 57.3)

48.7% (44.2 - 52.9)

LFS (95% CI)

56% (51.9 - 59.8)

46.3% (42.2 - 50.3)

42% (37.8 - 46.1)

RI (95% CI)

39.3% (35.4 - 43.1)

46.8% (42.7 - 50.7)

48.9% (44.7 - 53)

NRM (95% CI)

4.8% (3.3 - 6.6)

6.9% (5 - 9.2)

9.1% (6.8 - 11.8)

  1. OS overall survival, LFS leukemia-free survival, RI relapse incidence, NRM non-relapse mortality, CI confidence interval